SENTIRIX, a New DiscoveryBioMed Unit Working With Monell Center Licensed Technology, Will Implement Human Taste Bud Cell Platform Technologies as a Valuable Screening and Profiling Tool for the Food, Beverage, Flavor & BioPharmaceutical Marketplaces
BIRMINGHAM, Ala.–(BUSINESS WIRE)–DiscoveryBioMed, Inc. (DBM, www.discoverybiomed.com) announces a new unit of its contract research organization (CRO) services business called Sentirix…